AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
187.11
+2.26 (1.22%)
At close: Jul 22, 2025, 4:00 PM
187.00
-0.11 (-0.06%)
Pre-market: Jul 23, 2025, 7:03 AM EDT
AbbVie Revenue
AbbVie had revenue of $13.34B in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.77
Revenue / Employee
$1,043,036
Employees
55,000
Market Cap
330.51B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 410.06B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.92B |
Novartis AG | 55.19B |
AstraZeneca | 54.98B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
Abbott Laboratories | 43.11B |
ABBV News
- 19 hours ago - 4 Reasons To Buy AbbVie - Seeking Alpha
- 21 hours ago - Best Dividend Kings: July 2025 - Seeking Alpha
- 23 hours ago - BOTOX® Cosmetic (onabotulinumtoxinA) Selects This Year's Entrepreneurs for The Confidence Project - PRNewsWire
- 1 day ago - Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields - Benzinga
- 4 days ago - July's 5 Dividend Growth Stocks With Yields Up To 7.96% - Seeking Alpha
- 5 days ago - Why AbbVie Is a Strong Buy for Long-Term Investors in 2025 - FXEmpire
- 6 days ago - My Top 2 Earnings Picks For This Earnings Season - Benzinga
- 11 days ago - A Sweet Spot Between Yield And Growth: The Best Balanced Dividend Growers For 2025 - Seeking Alpha